Please assess the completion status of the following clinical trial:

Trial Title: Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \>18yr~Exclusion Criteria:~* Lack of informed consent~* Age \< 18 years,~* Current involvement in other research studies,~* Systolic blood pressure \>190 mmHg or \<100 mmHg~* Malignant arrhythmias~* Renal or hepatic failure~* Haemodynamically significant aortic stenosis~* Severe or significant co morbidity~* Women of childbearing potential.~* Any regular medication~* Previous history of any cardiovascular disease

- Gender: ALL
- Minimum Age: 18 Months
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Sodium depletion (Type: EXPERIMENTAL): Subjects will be randomised to normal diet or sodium depleted diet. The sodium depletion protocol comprises of a single oral dose of 40 mg of furosemide followed by an out-patient diet containing \>2000 kcal of energy, \>60 g of protein, \<12 mmol of sodium and \<70 mmol of potassium per day for 3 days prior to study. This diet is know to increase the activity of the renin-angiotensin system.
- Normal diet (Type: PLACEBO_COMPARATOR): Subjects will be randomised to a normal diet, with no restriction on sodium intake during the three days prior to the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).